Dr. Elizabeth Bishop Gausden, MD

Dr. Gausden practices at Hospital for Special Surgery in New York, New York, part of Hospital for Special Surgery.

Dr. Gausden's NPI, 1255699526, was assigned on April 24, 2012. Dr. Gausden graduated from Weill Cornell Medicine in 2012. Dr. Gausden holds New York license 272406.

Dr. Gausden's primary practice is Hospital for Special Surgery, at 535 East 70th Street, New York, NY 10021 in New York County. The practice phone is (212) 606-1000.

Dr. Gausden's primary practice is Hospital for Special Surgery in New York, New York, part of Hospital for Special Surgery. Dr. Gausden is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Hospital for Special Surgery (HSS). Dmand AI also links Dr. Gausden to 2 more hospitals and 5 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gausden practices, 9 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Gausden's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Gausden is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Gausden's licenses on file in 4 states: New York, Connecticut, Minnesota and Wisconsin.

Dmand AI lists arthritis, bursitis, fluid in a joint, hip replacement, joint pain, knee replacement, lower back pain and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Gausden treats.

CMS data shows 2,905 Medicare services from Dr. Gausden across 13 procedure codes in 2024, for 543 Medicare patients. Medicare paid $372,786 for them.

CMS counts 543 Medicare patients who saw Dr. Gausden in 2024. The largest group is 65 to 74, with 280 patients. 75% of them have arthritis, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gausden's median patient age at 70, with 71% women.

In 2024, Dr. Gausden wrote 140 Medicare Part D claims for 83 patients. 99% of them were for generic drugs. CMS names the drug for 109 of them, across 3 drugs with 11 or more claims each, at $292 in total drug cost. In 2023, CMS named 171 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gausden for performance year 2024, reported as part of a group. Dr. Gausden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 135 procedures of hip replacement by Dr. Gausden, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 99 papers to Dr. Gausden, published from 2009 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Arthroplasty, Replacement, Hip, Reoperation and Fracture Fixation, Internal. Dr. Gausden has published most often in J Arthroplasty. Dr. Gausden's most frequent co-authors are Brian P. Chalmers, MD, Peter Keyes Sculco, MD and Stephen J. Warner.

CMS Open Payments shows 508 general payments to Dr. Gausden from 14 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 80% of the total. Stryker Corporation paid the most, $329,559.

Dr. Gausden graduated from Weill Cornell Medicine in 2012.

Dr. Gausden is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.